CRMD Q1 2026 Earnings Profit Surge Driven by NonOperating Items Revenue Remains Absent TRVI Q1 2026 Earnings WiderthanExpected Loss Amid PreRevenue Development Stage Autolus Therapeutics Q1 2026 Earnings EPS Miss Reflects Ongoing RD Investment SPCE Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Surge IGC Q1 2026 Earnings Narrowing Losses as Cost Discipline Drives EPS Beat POET Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Stage